Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Current Urology Reports
Published in: Current Urology Reports 6/2010

01-11-2010

Overactive Bladder and Mixed Incontinence

Authors: Sunshine Murray, Gary E. Lemack

Published in: Current Urology Reports | Issue 6/2010

Login to get access

Abstract

Mixed urinary incontinence (MUI) is a complex problem and a difficult one to treat. Successful outcome associated with treatment depends on alleviation of not one, but two symptoms. This review addresses the definition, etiology, workup, and treatment of MUI. It encompasses conservative, pharmacological, and surgical therapies along with their outcomes in these complicated patients.
Literature
1.
Stewart WF, Van Rooyen JB, Cundiff GW, et al.: Prevalence and burden of overactive bladder in the United States. World J Urol 2003, 20:327–336.PubMed
2.
Hannestad YS, Rortveit G, Sandvik H, Hunskaar S: A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trondelag. J Clin Epidemiol 2000, 53:1150–1157.CrossRefPubMed
3.
• Minassian VA, Stewart WF, Wood GC: Urinary incontinence in women: variation in prevalence estimates and risk factors. Obstet Gynecol 2008, 111:324–331. This is an epidemiological study based on the National Health and Nutrition Examination Survey 2001-2002 data looking at the prevalence and risk factors of urinary incontinence.PubMed
4.
Papanicolaou S, Pons ME, Hampel C, et al.: Medical resource utilisation and cost of care for women seeking treatment for urinary incontinence in an outpatient setting. Examples from three countries participating in the PURE study. Maturitas 2005, 52(Suppl 2):S35–S47.CrossRefPubMed
5.
Grimby A, Milsom I, Molander U, et al.: The influence of urinary incontinence on the quality of life of elderly women. Age Ageing 1993, 22:82–89.CrossRefPubMed
6.
Chiaffarino F, Parazzini F, Lavezzari M, Giambanco V: Impact of urinary incontinence and overactive bladder on quality of life. Eur Urol 2003, 43:535–538.CrossRefPubMed
7.
• Frick AC, Huang AJ, Van den Eeden SK, et al.: Mixed urinary incontinence: greater impact on quality of life. J Urol 2009, 182:596–600. This cross-sectional analysis of a population-based cohort of 2109 women looked at prevalence of incontinence and disease-specific QOL impact between SUI, UUI, and MUI.CrossRefPubMed
8.
Papanicolaou S, Hunskaar S, Lose G, Sykes D: Assessment of bothersomeness and impact on quality of life of urinary incontinence in women in France, Germany, Spain and the UK. BJU Int 2005, 96:831–838.CrossRefPubMed
9.
• Schimpf MO, Patel M, O’Sullivan DM, Tulikangas PK: Difference in quality of life in women with urge urinary incontinence compared to women with stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2009, 20:781–786. This retrospective review of 465 women with UUI, SUI, or MUI and control patients (no incontinence) evaluating quality of life with prospectively obtained questionnaires found that women with UUI or MUI have lower quality-of-life scores than control patients and those with SUI alone.CrossRefPubMed
10.
Coyne KS, Zhou Z, Thompson C, Versi E: The impact on health-related quality of life of stress, urge and mixed urinary incontinence. BJU Int 2003, 92:731–735.CrossRefPubMed
11.
Melville JL, Delaney K, Newton K, Katon W: Incontinence severity and major depression in incontinent women. Obstet Gynecol 2005, 106:585–592.PubMed
12.
Nygaard I, Turvey C, Burns TL, et al.: Urinary incontinence and depression in middle-aged United States women. Obstet Gynecol 2003, 101:149–156.CrossRefPubMed
13.
• Haylen BT, de Ridder D, Freeman RM, et al.: An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010, 29:4–20. This is an update on the terminology used in female pelvic floor dysfunction providing standard definitions for commonly used terms in the field.PubMed
14.
Jung SY, Fraser MO, Ozawa H, et al.: Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability. J Urol 1999, 162:204–212.CrossRefPubMed
15.
Koonings PP, Bergman A: Urethral pressure changes in women with detrusor instability. Bladder or urethral pathologic process? Urology 1991, 37:540–542.CrossRefPubMed
16.
Wise BG, Cardozo LD, Cutner A, et al.: Prevalence and significance of urethral instability in women with detrusor instability. Br J Urol 1993, 72:26–29.CrossRefPubMed
17.
Koonings P, Bergman A, Ballard CA: Combined detrusor instability and stress urinary incontinence: where is the primary pathology? Gynecol Obstet Invest 1988, 26:250–256.CrossRefPubMed
18.
Major H, Culligan P, Heit M: Urethral sphincter morphology in women with detrusor instability. Obstet Gynecol 2002, 99:63–68.CrossRefPubMed
19.
• Gamble TL, Botros SM, Beaumont JL, et al.: Predictors of persistent detrusor overactivity after transvaginal sling procedures. Am J Obstet Gynecol 2008, 199:696.e1–696.e7. This retrospective review looked at 305 women with MUI who underwent sling, finding that transobturator slings had the lowest rate of persistent DO. Other predictors of persistent DO included age, nocturia, maximum cystometric capacity, DO volume, urethral closure pressure, and maximum urinary flow rate.CrossRef
20.
• Alperin M, Abrahams-Gessel S, Wakamatsu MM: Development of de novo urge incontinence in women post sling: the role of preoperative urodynamics in assessing the risk. Neurourol Urodyn 2008, 27:407–411. This is a retrospective review of 92 women undergoing sling surgery, of which 25 developed de novo UUI. When looking at clinical and urodynamic predictors of de novo UUI, only increased daytime frequency and filling detrusor pressure greater than 15 cm H 2 O were found to be predictors.CrossRefPubMed
21.
Khullar V, Hill S, Laval KU, et al.: Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial. Urology 2004, 64:269–274.CrossRefPubMed
22.
Bump RC, Norton PA, Zinner NR, Yalcin I: Mixed urinary incontinence symptoms: urodynamic findings, incontinence severity, and treatment response. Obstet Gynecol 2003, 102:76–83.CrossRefPubMed
23.
Hashim H, Abrams P: Is the bladder a reliable witness for predicting detrusor overactivity? J Urol 2006, 175:191–194.CrossRefPubMed
24.
Digesu GA, Khullar V, Cardozo L, Salvatore S: Overactive bladder symptoms: do we need urodynamics? Neurourol Urodyn 2003, 22:105–108. (Published erratum appears in Neurourol Urodyn 2003, 22:356.)CrossRefPubMed
25.
• Digesu GA, Salvatore S, Fernando R, Khullar V: Mixed urinary symptoms: what are the urodynamic findings? Neurourol Urodyn 2008, 27:372–375. This is a retrospective review of 1626 women who reported MUI at referral to a tertiary referral center for urodynamics that found women with urge-predominant MUI, based on questionnaire data, are more likely to have DO on urodynamics and those with stress-predominant MUI are more likely to have urodynamic stress incontinence.CrossRefPubMed
26.
Kuo HC: Effect of detrusor function on the therapeutic outcome of a suburethral sling procedure using a polypropylene sling for stress urinary incontinence in women. Scand J Urol Nephrol 2007, 41:138–143.CrossRefPubMed
27.
• Stoffel JT, Smith JJ, Crivellaro S, Bresette JF: Mixed incontinence: does preoperative urodynamic detrusor overactivity affect postoperative quality of life after pubovaginal sling? Int Braz J Urol 2008, 34:765–771. This retrospective review looking at 73 women who underwent pubovaginal sling for treatment of MUI, both with and without DO, found similar reductions in daily pad usage, but smaller improvement in UDI-6 scores among those with DO when compared to those without.CrossRefPubMed
28.
• Panayi DC, Duckett J, Digesu GA, et al.: Pre-operative opening detrusor pressure is predictive of detrusor overactivity following TVT in patients with pre-operative mixed urinary incontinence. Neurourol Urodyn 2009, 28:82–85. This is a retrospective review of 51 women with both urodynamic SUI and DO who underwent TVT, of which 35 had postoperative UDS. Of the studied patients, 19 had persistent DO postoperatively, with the only significant difference found between those with and without persistent DO being higher median preoperative opening detrusor pressure.CrossRefPubMed
29.
Waetjen LE, Liao S, Johnson WO, et al.: Factors associated with prevalent and incident urinary incontinence in a cohort of midlife women: a longitudinal analysis of data: study of women’s health across the nation. Am J Epidemiol 2007, 165:309–318.CrossRefPubMed
30.
Danforth KN, Townsend MK, Lifford K, et al.: Risk factors for urinary incontinence among middle-aged women. Am J Obstet Gynecol 2006, 194:339–345.CrossRefPubMed
31.
Subak LL, Whitcomb E, Shen H, et al.: Weight loss: a novel and effective treatment for urinary incontinence. J Urol 2005, 174:190–195.CrossRefPubMed
32.
Burgio KL, Richter HE, Clements RH, et al.: Changes in urinary and fecal incontinence symptoms with weight loss surgery in morbidly obese women. Obstet Gynecol 2007, 110:1034–1040.PubMed
33.
• Subak LL, Wing R, West DS, et al.: Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med 2009, 360:481–490. This is a randomized controlled trial of 338 overweight and obese women with urinary incontinence randomized to an intensive weight-loss program and behavior modification or to a structured education program. Women in the weight-loss program lost significantly more weight after 6 months and had a significantly large decrease in the number of weekly incontinence episodes when compared to those in the education group.CrossRefPubMed
34.
• Dumoulin C, Hay-Smith J: Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev 2010, (1):CD005654. This Cochrane review of 12 trials (672 women) looks at the effects of pelvic floor muscle training for urinary incontinence compared to no treatment, placebo, or inactive control, which found fewer incontinence episodes as well as better quality of life in those undergoing pelvic floor muscle training as compared to control patients.
35.
• Sar D, Khorshid L: The effects of pelvic floor muscle training on stress and mixed urinary incontinence and quality of life. J Wound Ostomy Continence Nurs 2009, 36:429–435. This is a randomized controlled trial of 41 women with SUI or MUI randomized to pelvic floor muscle training for 8 weeks or no intervention. Those randomized to pelvic floor muscle training had significant differences in the 1-hour pad test, episodes of leakage on a 3-day voiding diary, and I-QOL scores after 8 weeks when compared to control patients.PubMed
36.
Hashim H, Abrams P: Pharmacological management of women with mixed urinary incontinence. Drugs 2006, 66:591–606.CrossRefPubMed
37.
Dmochowski RR, Davila GW, Zinner NR, et al.: Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence. J Urol 2002, 168:580–586.CrossRefPubMed
38.
Kreder KJ Jr, Brubaker L, Mainprize T: Tolterodine is equally effective in patients with mixed incontinence and those with urge incontinence alone. BJU Int 2003, 92:418–421.CrossRefPubMed
39.
• Bent AE, Gousse AE, Hendrix SL, et al.: Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence. Neurourol Urodyn 2008, 27:212–221. This is a randomized, placebo-controlled, double-blind clinical trial looking at 588 women with MUI randomized to duloxetine, 80 mg daily, or placebo. Overall incontinence episodes frequency as well as stress and urge incontinence episode decreases were significantly greater with duloxetine when compared to placebo.CrossRefPubMed
40.
Debodinance P, Delporte P, Engrand JB, Boulogne M: Tension-free vaginal tape (TVT) in the treatment of urinary stress incontinence: 3 years experience involving 256 operations. Eur J Obstet Gynecol Reprod Biol 2002, 105:49–58.CrossRefPubMed
41.
Schrepferman CG, Griebling TL, Nygaard IE, Kreder KJ: Resolution of urge symptoms following sling cystourethropexy. J Urol 2000, 164:1628–1631.CrossRefPubMed
42.
• Tahseen S, Reid P: Effect of transobturator tape on overactive bladder symptoms and urge urinary incontinence in women with mixed urinary incontinence. Obstet Gynecol 2009, 113:617–623. This article reviews telephone questionnaires completed by patients with SUI, stress-predominant MUI, and urge-predominant SUI who underwent transobturator sling for treatment. UUI was cured in 43% of patients, improved in 36%, and persistent in 21%. No patients with SUI alone preoperatively reported de novo UUI postoperatively.PubMed
43.
Holmgren C, Nilsson S, Lanner L, Hellberg D: Long-term results with tension-free vaginal tape on mixed and stress urinary incontinence. Obstet Gynecol 2005, 106:38–43.PubMed
44.
• Kulseng-Hanssen S, Husby H, Schiotz HA: Follow-up of TVT operations in 1,113 women with mixed urinary incontinence at 7 and 38 months. Int Urogynecol J Pelvic Floor Dysfunct 2008, 19:391–396. This is a retrospective review of 1113 women with MUI who underwent TVT, looking at outcomes in those with stress predominance, urge predominance, and equivalent stress and urge bother at 7 and 38 months. Those with stress predominance more often were dry during pad test, very satisfied, and objectively and subjectively cured when compared to those with urge predominance and equivalent bother; however, at 38 months, 60% and 73% of these patients, respectively, reported being very satisfied.CrossRefPubMed
45.
Ankardal M, Heiwall B, Lausten-Thomsen N, et al.: Short- and long-term results of the tension-free vaginal tape procedure in the treatment of female urinary incontinence. Acta Obstet Gynecol Scand 2006, 85:986–992.CrossRefPubMed
46.
Chêne G, Amblard J, Tardieu AS, et al.: Long-term results of tension-free vaginal tape (TVT) for the treatment of female urinary stress incontinence. Eur J Obstet Gynecol Reprod Biol 2007, 134:87–94.CrossRefPubMed
47.
Osman T: Stress incontinence surgery for patients presenting with mixed incontinence and a normal cystometrogram. BJU Int 2003, 92:964–968.CrossRefPubMed
48.
• Kenton K, Richter H, Litman H, et al.: Risk factors associated with urge incontinence after continence surgery. J Urol 2009, 182:2805–2809. This secondary analysis of data from the Stress Incontinence Surgical Treatment Efficacy trial, looking at risk factors for development of postoperative UUI after Burch colposuspension or autologous fascia sling, found that the odds were higher for development of postoperative UUI in those undergoing sling as well as those with prior anticholinergic use, preoperative DO, and higher MESA urge score.CrossRefPubMed
49.
Botros SM, Abramov Y, Goldberg RP, et al.: Detrusor overactivity and urge urinary incontinence [corrected] following midurethral versus bladder sling procedures. Am J Obstet Gynecol 2005, 193:2144–2148. (Published erratum appears in Am J Obstet Gynecol 2006, 194:595.)CrossRefPubMed
50.
• Paick JS, Oh SJ, Kim SW, Ku JH: Tension-free vaginal tape, suprapubic arc sling, and transobturator tape in the treatment of mixed urinary incontinence in women. Int Urogynecol J Pelvic Floor Dysfunct 2008, 19:123–129. This retrospective review of 144 women with MUI who underwent sling found that preoperative low maximum urethral closure pressure and DO both were associated with increased likelihood of treatment failure of UUI.PubMed
51.
• Brubaker L, Stoddard A, Richter H, et al.: Mixed incontinence: comparing definitions in women having stress incontinence surgery. Neurourol Urodyn 2009, 28:268–273. This secondary analysis of data from the Stress Incontinence Surgical Treatment Efficacy trial attempts to define MUI with both the MESA score and bother based on the UDI. The definitions then were evaluated against the trial’s clinical outcomes, and the authors found that very little of the variability was explained by any of the MUI definitions tested.CrossRefPubMed
52.
Doo CK, Hong B, Chung BJ, et al.: Five-year outcomes of the tension-free vaginal tape procedure for treatment of female stress urinary incontinence. Eur Urol 2006, 50:333–338.CrossRefPubMed
53.
Chou EC, Flisser AJ, Panagopoulos G, Blaivas JG: Effective treatment for mixed urinary incontinence with a pubovaginal sling. J Urol 2003, 170:494–497.CrossRefPubMed
54.
Trockman BA, Leach GE, Hamilton J, et al.: Modified Pereyra bladder neck suspension: 10-year mean followup using outcomes analysis in 125 patients. J Urol 1995, 154:1841–1847.CrossRefPubMed
Metadata
Title
Overactive Bladder and Mixed Incontinence
Authors
Sunshine Murray
Gary E. Lemack
Publication date
01-11-2010
Publisher
Current Science Inc.
Published in
Current Urology Reports / Issue 6/2010
Print ISSN: 1527-2737
Electronic ISSN: 1534-6285
DOI
https://doi.org/10.1007/s11934-010-0146-0

Other articles of this Issue 6/2010

Current Urology Reports 6/2010 Go to the issue

ReviewPaper

New Concepts in the Diagnosis and Treatment of Premature Ejaculation

CLINICAL TRIAL REPORT

Need for Standardization in Definition of Success in Clinical Trials on Stress Urinary Incontinence

ReviewPaper

Recent Advances in the Medical and Surgical Treatment of Priapism

ReviewPaper

Overactive Bladder and Pain: Management Strategies

ReviewPaper

Traumatic Vasculogenic Erectile Dysfunction: Role of Penile Microarterial Bypass Surgery

ReviewPaper

Gene Therapy for Erectile Dysfunction: What Is the Future?